Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 452,624 shares of the semiconductor company’s stock, valued at approximately $201,902,000. Connor Clark & Lunn Investment Management Ltd. owned about 0.24% of Synopsys at the end of the most recent quarter.
A number of other hedge funds have also bought and sold shares of the business. Brighton Jones LLC grew its stake in Synopsys by 5.7% in the 4th quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock valued at $447,000 after purchasing an additional 50 shares during the period. Integrated Wealth Concepts LLC raised its stake in shares of Synopsys by 11.6% during the 1st quarter. Integrated Wealth Concepts LLC now owns 760 shares of the semiconductor company’s stock worth $326,000 after purchasing an additional 79 shares during the period. NewEdge Advisors LLC boosted its holdings in shares of Synopsys by 15.1% in the 1st quarter. NewEdge Advisors LLC now owns 3,010 shares of the semiconductor company’s stock worth $1,291,000 after buying an additional 395 shares during the last quarter. WINTON GROUP Ltd boosted its holdings in shares of Synopsys by 9.2% in the 2nd quarter. WINTON GROUP Ltd now owns 758 shares of the semiconductor company’s stock worth $389,000 after buying an additional 64 shares during the last quarter. Finally, Treasurer of the State of North Carolina grew its position in Synopsys by 2.1% during the second quarter. Treasurer of the State of North Carolina now owns 72,095 shares of the semiconductor company’s stock valued at $36,962,000 after buying an additional 1,505 shares during the period. 85.47% of the stock is currently owned by institutional investors.
Synopsys Price Performance
Synopsys stock opened at $397.87 on Monday. The firm has a 50 day simple moving average of $419.73 and a 200 day simple moving average of $440.09. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 1-year low of $366.00 and a 1-year high of $615.79. The firm has a market capitalization of $76.18 billion, a price-to-earnings ratio of 92.10, a P/E/G ratio of 2.34 and a beta of 1.23.
Insider Activity
In other news, CEO Sassine Ghazi sold 14,603 shares of the company’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the sale, the chief executive officer directly owned 75,020 shares in the company, valued at $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the sale, the chief financial officer directly owned 14,358 shares in the company, valued at approximately $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.56% of the company’s stock.
Wall Street Analysts Forecast Growth
SNPS has been the subject of a number of research analyst reports. Robert W. Baird set a $558.00 price objective on shares of Synopsys in a report on Thursday, May 28th. Berenberg Bank set a $633.00 target price on shares of Synopsys in a research report on Wednesday, May 27th. Piper Sandler upgraded shares of Synopsys from a “neutral” rating to an “overweight” rating and raised their price target for the stock from $450.00 to $550.00 in a research note on Tuesday, June 23rd. Rosenblatt Securities upped their price objective on Synopsys from $530.00 to $575.00 and gave the company a “buy” rating in a research note on Tuesday, May 26th. Finally, Citigroup increased their price objective on Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, May 28th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $563.59.
Get Our Latest Stock Analysis on Synopsys
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
